JW Therapeutics
Shanghai based therapeutics platform.
Launch date
Employees
Market cap
$62.6m
Enterprise valuation
($28m) (Public information from Sep 2024)
Share price
HKD1.3 2126.HK
Shanghai Shanghai (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | - | 30.8m | 146m | 174m | 254m | 404m | 661m |
| % growth | - | - | 373 % | 19 % | 46 % | 59 % | 63 % |
| EBITDA | (1.6b) | (700m) | (752m) | (474m) | (547m) | (449m) | (363m) |
| % EBITDA margin | - | (2274 %) | (516 %) | (272 %) | (215 %) | (111 %) | (55 %) |
| Profit | (1.7b) | (702m) | (846m) | (768m) | (634m) | (548m) | (386m) |
| % profit margin | - | (2281 %) | (581 %) | (442 %) | (250 %) | (136 %) | (58 %) |
| EV / revenue | - | 86.3x | 3.0x | 0.8x | -0.1x | 1.0x | 1.1x |
| EV / EBITDA | -3.8x | -3.8x | -0.6x | -0.3x | 0.1x | -0.9x | -2.0x |
| R&D budget | 225m | 414m | 408m | 414m | - | - | - |
| R&D % of revenue | - | 1346 % | 280 % | 238 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
$90.0m | Series A | ||
$100m | Series B | ||
| N/A | $300m | IPO | |
| Total Funding | $190m | ||
Related Content
Recent News about JW Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.